1935 related articles for article (PubMed ID: 7951003)
21. Differential effects of TGF-beta 1 on normal and leukemic human hematopoietic cell proliferation.
Murohashi I; Endho K; Nishida S; Yoshida S; Jinnai I; Bessho M; Hirashima K
Exp Hematol; 1995 Aug; 23(9):970-7. PubMed ID: 7543418
[TBL] [Abstract][Full Text] [Related]
22. Leukemia suppressor function of Egr-1 is dependent on transforming oncogene.
Gibbs JD; Liebermann DA; Hoffman B
Leukemia; 2008 Oct; 22(10):1909-16. PubMed ID: 18650844
[TBL] [Abstract][Full Text] [Related]
23. The AML1 gene: a transcription factor involved in the pathogenesis of myeloid and lymphoid leukemias.
Lo Coco F; Pisegna S; Diverio D
Haematologica; 1997; 82(3):364-70. PubMed ID: 9234595
[TBL] [Abstract][Full Text] [Related]
24. Deregulated c-myb disrupts interleukin-6- or leukemia inhibitory factor-induced myeloid differentiation prior to c-myc: role in leukemogenesis.
Selvakumaran M; Liebermann DA; Hoffman-Liebermann B
Mol Cell Biol; 1992 Jun; 12(6):2493-500. PubMed ID: 1588953
[TBL] [Abstract][Full Text] [Related]
25. Ectopic expression of MyD118/Gadd45/CR6 (Gadd45beta/alpha/gamma) sensitizes neoplastic cells to genotoxic stress-induced apoptosis.
Zhang W; Hoffman B; Liebermann DA
Int J Oncol; 2001 Apr; 18(4):749-57. PubMed ID: 11251170
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of PC-12 cell differentiation by the immediate early gene fra-1.
Ito E; Sweterlitsch LA; Tran PB; Rauscher FJ; Narayanan R
Oncogene; 1990 Dec; 5(12):1755-60. PubMed ID: 2178237
[TBL] [Abstract][Full Text] [Related]
27. c-myc and c-myb oncoproteins during induced maturation of myeloid and erythroid human leukemic cell lines.
Pedrazzoli P; Bains MA; Watson R; Fisher J; Hoy TG; Jacobs A
Cancer Res; 1989 Dec; 49(24 Pt 1):6911-6. PubMed ID: 2684403
[TBL] [Abstract][Full Text] [Related]
28. Differential regulation and expression of jun, c-fos and c-myc proto-oncogenes during mouse liver regeneration and after inhibition of protein synthesis.
Morello D; Lavenu A; Babinet C
Oncogene; 1990 Oct; 5(10):1511-9. PubMed ID: 2123531
[TBL] [Abstract][Full Text] [Related]
29. Molecular mechanisms of leukemogenesis by AML1/EVI-1.
Mitani K
Oncogene; 2004 May; 23(24):4263-9. PubMed ID: 15156182
[TBL] [Abstract][Full Text] [Related]
30. Deregulated c-Myb expression in murine myeloid leukemias prevents the up-regulation of p15(INK4b) normally associated with differentiation.
Schmidt M; Koller R; Haviernik P; Bies J; Maciag K; Wolff L
Oncogene; 2001 Sep; 20(43):6205-14. PubMed ID: 11593429
[TBL] [Abstract][Full Text] [Related]
31. Growth factor-mediated terminal differentiation of chronic myeloid leukemia.
Bedi A; Griffin CA; Barber JP; Vala MS; Hawkins AL; Sharkis SJ; Zehnbauer BA; Jones RJ
Cancer Res; 1994 Nov; 54(21):5535-8. PubMed ID: 7923192
[TBL] [Abstract][Full Text] [Related]
32. Only late, nonmitotic stages of granulocyte differentiation in 32Dcl3 cells are blocked by ectopic expression of murine c-myb and its truncated forms.
Bies J; Mukhopadhyaya R; Pierce J; Wolff L
Cell Growth Differ; 1995 Jan; 6(1):59-68. PubMed ID: 7536440
[TBL] [Abstract][Full Text] [Related]
33. The novel primary response gene MyD118 and the proto-oncogenes myb, myc, and bcl-2 modulate transforming growth factor beta 1-induced apoptosis of myeloid leukemia cells.
Selvakumaran M; Lin HK; Sjin RT; Reed JC; Liebermann DA; Hoffman B
Mol Cell Biol; 1994 Apr; 14(4):2352-60. PubMed ID: 8139540
[TBL] [Abstract][Full Text] [Related]
34. Myeloid differentiation (MyD) primary response genes in hematopoiesis.
Liebermann DA; Hoffman B
Blood Cells Mol Dis; 2003; 31(2):213-28. PubMed ID: 12972029
[TBL] [Abstract][Full Text] [Related]
35. Myeloblastic leukemia cells conditionally blocked by myc-estrogen receptor chimeric transgenes for terminal differentiation coupled to growth arrest and apoptosis.
Selvakumaran M; Liebermann D; Hoffman-Liebermann B
Blood; 1993 May; 81(9):2257-62. PubMed ID: 8481508
[TBL] [Abstract][Full Text] [Related]
36. Myeloid differentiation (MyD)/growth arrest DNA damage (GADD) genes in tumor suppression, immunity and inflammation.
Liebermann DA; Hoffman B
Leukemia; 2002 Apr; 16(4):527-41. PubMed ID: 11960329
[TBL] [Abstract][Full Text] [Related]
37. The zinc finger transcription factor Egr-1 activates macrophage differentiation in M1 myeloblastic leukemia cells.
Krishnaraju K; Hoffman B; Liebermann DA
Blood; 1998 Sep; 92(6):1957-66. PubMed ID: 9731053
[TBL] [Abstract][Full Text] [Related]
38. Suppression of c-myc and c-myb is tightly linked to terminal differentiation induced by IL6 or LIF and not growth inhibition in myeloid leukemia cells.
Hoffman-Liebermann B; Liebermann DA
Oncogene; 1991 Jun; 6(6):903-9. PubMed ID: 1906157
[TBL] [Abstract][Full Text] [Related]
39. Egr-1 abrogates the block imparted by c-Myc on terminal M1 myeloid differentiation.
Shafarenko M; Liebermann DA; Hoffman B
Blood; 2005 Aug; 106(3):871-8. PubMed ID: 15840692
[TBL] [Abstract][Full Text] [Related]
40. Suppression of interleukin-3-induced gene expression by a C-terminal truncated Stat5: role of Stat5 in proliferation.
Mui AL; Wakao H; Kinoshita T; Kitamura T; Miyajima A
EMBO J; 1996 May; 15(10):2425-33. PubMed ID: 8665850
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
